Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Behind The Scenes: How Smart Storage Keeps Healthcare Running Smoothly
Smart storage systems are becoming essential in healthcare facilities, safeguarding medications, patient records, and equipment through locked cabinets and digital tracking. Organized layouts and frequency‑based shelving cut staff search time, allowing more focus on patient care. Real‑time inventory platforms alert teams to low stock and expiration dates, reducing waste and preventing shortages. Modular, temperature‑controlled units provide the flexibility needed to adapt quickly to shifting clinical demands and regulatory changes.
Two Breaches, One Quarter: Valley Family Health Care’s Challenging Start to 2026
Valley Family Health Care (VFHC) disclosed a TriZetto Provider Solutions breach on Jan. 12 that exposed the personal and health‑insurance data of 4,300 patients. In March, the cyber‑crime group Insomnia listed VFHC on a dark‑web leak, claiming more than one million...
WHO Launches Year-Long Science-Driven Wellness Campaign on World Health Day
The World Health Organization announced on April 7, 2026 that World Health Day will launch a year-long campaign titled “Together for Health. Stand with Science.” The initiative aims to foreground evidence‑based wellness practices and coordinate public‑health messaging across nations.
Placental Abruption Raises Offsprings’ Risk for Heart Disease, Death
A new study published in the Journal of the American Heart Association finds that children born after a placental abruption face a dramatically higher risk of cardiovascular disease and death by age 28. The analysis of 2,949,992 singleton pregnancies from...
Catalyst MedTech Establishes Full Access Neurology Solution for Brain PET Implementation in the U.S.
Catalyst MedTech announced the nationwide rollout of its Full Access Neurology solution, a bundled offering that enables health systems to deploy dedicated brain PET imaging without large capital outlays. The platform combines CareMiBrain‑powered scanners, quantification software, service and maintenance, and...
Semaglutide Cuts Cardiac Risk 20% and Retatrutide Hits All Diabetes Endpoints
Eli Lilly announced that its triple‑agonist retatrutide met all primary and key secondary endpoints in the phase‑3 TRANSCEND‑T2D‑1 trial, delivering significant HbA1c and weight reductions. In parallel, the SELECT trial confirmed that semaglutide lowered major adverse cardiovascular events by 20% in...
Pfizer's Late-Stage Lyme Vaccine Shows 73% Efficacy but Misses Primary Endpoint
Pfizer announced a late‑stage Lyme disease vaccine candidate that achieved 73.2% efficacy 28 days after the fourth dose, but the study missed its primary endpoint because of lower-than-expected case numbers. The vaccine, a monoclonal antibody developed with MassBiologics, will now...
A Target for Ameliorating Post-Operative Delirium
Researchers identified the chromatin remodeler RUVBL2 as a key driver of metabolic reprogramming in microglia that underlies post‑operative delirium in aged rats. Suppressing RUVBL2 reversed the glycolytic shift, boosted ATP production, reduced stress‑granule accumulation, and restored performance on Barnes maze...
CRISPR Therapeutics' One‑Time Gene Edit Cuts LDL by 49% in Early Trial
CRISPR Therapeutics reported that a one‑time CRISPR‑based therapy turned off the liver gene ANGPTL3, dropping LDL cholesterol by 49% and triglycerides by 55% in the highest‑dose cohort of a 15‑patient trial. The results, published in the New England Journal of...
Inside The Sterile Barrier: How Containment Protects Quality In Healthcare
Healthcare providers rely on sterile barrier systems to keep medical devices and products free from microbial contamination. By integrating robust packaging, sealing methods, and controlled storage, these barriers protect patient safety throughout the product lifecycle. Mapping each handling, transport, and...
Arizona Cardiology Practice Paying $3.85M to Resolve Lawsuit After Data Breach
Cardiovascular Consultants, a Phoenix cardiology practice owned by Fresenius Medical Care, agreed to pay $3.85 million to settle a class‑action lawsuit stemming from a September 2023 data breach. The breach potentially exposed personal data of 500,000 patients and 200 employees, including Social...
RFK Jr. Gains Expanded Authority Over ACIP Vaccine Committee in New Federal Charter
The Federal Register released a revised charter for the Advisory Committee on Immunization Practices (ACIP) on Monday, granting Robert F. Kennedy Jr. expanded authority over the panel. The change eliminates prior expertise requirements, prompting lawsuits, a federal judge’s pause, and...
Lost In The Hallway: Why Navigation Stress Matters In Healthcare Facilities
Healthcare facilities often suffer from confusing layouts, poor signage, and inadequate wayfinding tools, leading to heightened patient stress and missed appointments. The article highlights how clear signage, color‑coded cues, and consistent design can streamline navigation. It also emphasizes the role...
Corewell Health Sees Big Benefits From Its Remote Patient Monitoring Investments
Corewell Health, a Michigan nonprofit system, partnered with Cadence to embed remote patient monitoring (RPM) into primary‑care workflows for hypertension, diabetes and heart‑failure patients. The program achieved over 80% patient engagement and delivered measurable clinical gains in four months, including...
Neurocrine to Acquire Soleno Therapeutics for $2.9 Billion in Cash
Neurocrine Pharmaceuticals has signed a definitive agreement to buy Soleno Therapeutics for $2.9 billion in cash, paying $53 per share—a 34% premium to Soleno’s April 2 close. The deal brings VYKAT XR, the only FDA‑approved drug for hyperphagia in Prader‑Willi syndrome, into Neurocrine’s...
BIO’s Comments for USTR Report Highlight Global Threats to Intellectual Property
The Biotechnology Innovation Organization (BIO) submitted comments to the USTR’s 2026 Special 301 Report urging stronger global enforcement of intellectual‑property (IP) rights for biotech. BIO argues that weak IP protections in markets such as Colombia, Russia and Brazil create barriers...
Vitamin D Shows Potential to Reduce Long COVID Symptoms: JoAnn E. Manson, MD, MPH, DrPH
A recent randomized VIVID trial examined vitamin D₃ supplementation in newly diagnosed COVID‑19 patients and found a non‑significant trend toward fewer long‑COVID symptoms at eight weeks. While primary outcomes such as healthcare utilization were unchanged, researchers noted that delayed treatment...
Other News to Note for April 6, 2026
Jiangsu and Shanghai Hengrui have patented selective Nav1.8 sodium‑channel blockers that show pre‑clinical analgesic efficacy with fewer side effects. New hematopoietic stem‑cell research links chronic inflammation to early leukemic transformation, identifying inflammatory pathways as therapeutic targets. Infinimmune presented pre‑clinical data...
Biopharma Financings Nearly Double Vs. 2025 to $25.1B
Biopharma financing nearly doubled year‑over‑year, reaching about $25.1 billion, fueling a wave of early‑stage research. Jiangsu and Shanghai Hengrui patented novel Nav1.8 sodium‑channel blockers aimed at chronic pain relief. New hematopoietic stem‑cell studies link inflammation to the earliest stages of leukemia,...
Regulatory Actions for April 6, 2026
BioWorld’s April 6, 2026 regulatory snapshot aggregates the day’s key FDA and global health authority actions across biopharma, medical technology, and diagnostics. The page links to data snapshots, special reports, infographics and trend analyses covering topics such as mRNA vaccine research, GLP‑1...
St. Luke’s Stays on Track with Massive Expansion
St. Luke's Medical Center announced it will proceed with a massive expansion despite rising costs from the Middle East crisis. The group plans to break ground on a new 500‑bed Aseana hospital in Parañaque costing about P18 billion (≈$324 million) with an...
Are Growth Rod Failure Rates Reliably Predictable?
A multicenter Pediatric Spine Study Group analysis of 118 early‑onset scoliosis patients undergoing growth guidance surgery (GGS) identified 173 hardware complications over a five‑year follow‑up. Rod fractures occurred in 32% of cases, especially when rods were ≤4.5 mm, and screw pullouts...
Vitamin D3 Preserves Telomeres, Slowing Cellular Aging
As a medical school professor, I have watched vitamin D research for decades. This trial finally delivers causal evidence. The VITAL randomized controlled trial -- the gold standard -- followed nearly 1,000 adults aged 50+ for 4 years and found that...
Over-the-Counter Medication Abortion? These Researchers Say It Would Be Safe
Researchers at UCSF surveyed 168 patients about a prototype over‑the‑counter medication abortion kit, finding 88% concordance between self‑assessment and clinician eligibility. The study, published in JAMA Internal Medicine, suggests patients can reliably determine suitability for mifepristone‑misoprostol regimens without a prescriber....
Amgen Seeks to Buoy Tepezza with Injectable Data in Face of Incoming Competition
Amgen announced that its injectable formulation of Tepezza achieved its primary endpoint in a Phase 3 trial for thyroid eye disease (TED). The data suggest the drug can be administered subcutaneously, offering a more convenient alternative to the current intravenous...
AI Turns Specialists Into Scalable Generalist‑Specialists in Healthcare
In @Health_Affairs Scholar, @bobkocher, Siobhan Nolan Mangini (both of @Venrock) and I argue that – by scaling specialist-level knowledge – AI will create, in essence, the "generalist-specialist." We explore the far-reaching implications for healthcare. https://t.co/FozKzBoINd
Many Teens Not Fully Vaccinated Against HPV Before Sexual Debut
New research published in JAMA Pediatrics shows that more than one‑fifth of adolescents in a Pennsylvania health system were either unvaccinated or incompletely vaccinated against HPV before becoming sexually active. While 79% completed the series before debut, 12% received no...
Machine Learning and Single-Cell Technology Combined to Drive High-Performance Cell Line Development
OneCyte and Kemp Proteins have formed a strategic partnership that fuses OneCyte’s high‑throughput single‑cell cloning platform with Kemp’s machine‑learning‑driven protein design system, PROTiQ. The combined workflow uses in‑silico sequence evaluation to flag developability risks, then rapidly screens thousands of clones...
Trump Proposes Cutting Medicare, Medicaid to Fund Wars
Trump says he wants to cut Medicare and Medicaid to pay for his fun little wars https://t.co/V1EQfyPLmS
Scaling Artificial Intelligence in Health
The OECD released a report outlining a policy checklist to scale artificial intelligence responsibly in health systems. It identifies four pillars—enablers, guardrails, meaningful engagement, and trustworthy deployment—covering nine policy categories and 43 guiding questions. The document highlights persistent barriers such...
Eli Lilly's Oral GLP‑1 Faces Price War Threat
6April: Why are @EliLillyandCo investors concerned that sales of its just-approved oral GLP-1 may be dampened this year by a price war with @novonordisk? Read about $LLY & $NOVOB plus updates on $INO $ORIC & $SGMO in my latest StockWatch for @GENbio: https://t.co/leir6iyURg
Hologic CEO Steve MacMillan to Retire After Go-Private Deal
Hologic announced that CEO Steve MacMillan will retire as the company completes a Blackstone‑TPG go‑private transaction valued at $18.3 billion. The deal, which received all regulatory approvals, will close Tuesday and delist Hologic from Nasdaq, paying shareholders $76 per share plus...
Anthropic Pays $400M for Biotech; Praxis Epilepsy Drug Hits in Phase 1/2 Trial
San Francisco AI firm Anthropic announced a $400 million acquisition of stealth biotech Coefficient Bio, signaling its push into drug discovery. The purchase aims to integrate Anthropic’s large‑language‑model capabilities with biotech research pipelines. In parallel, Praxis Therapeutics disclosed encouraging Phase 1/2 data...
ACSM Releases Definitive Guidance on Resistance Training
American College of Sports Medicine Position Stand on Resistance Training is here. #exercise #health #MedTwitter #CardioTwitter #lifestylemedicine #pavingwellness https://t.co/11XunfB41e
Takeda Ends Partnership with Denali Amid Restructuring
Takeda announced the termination of its eight‑year partnership with Denali Therapeutics, returning full rights to the experimental drug DNL593 ahead of its upcoming Phase I trial. The move is part of Takeda's broader restructuring aimed at streamlining its portfolio and...
UnitedHealth's $3 B AI Bet Promises Patient Benefits
UnitedHealth Group + AI +Polk winner @caseymross = A must read. $UNH is making a $3 billion bet on AI. What does it mean for patients? https://t.co/irkyZi8Wj6
60 Minutes Returns to Remote Area Medical
60 Minutes revisited Remote Area Medical (RAM), showing its expansion from 12 to 90 clinics and over one million patients served. The segment highlighted patients traveling hundreds of miles, sleeping in cars, and waiting in sub‑zero temperatures for basic dental...
Are Complete Dentures Right for You? Key Benefits Explained
The American Dental Association reports roughly 40.2 million U.S. adults are edentulous, underscoring a sizable market for tooth replacement. Modern complete dentures have evolved with digital scanning, computer‑aided design, and customized aesthetics, delivering better fit, comfort, and facial support. Immediate dentures...
Op-Ed | Dietary Guidelines for (Some) Americans: The Impact of Ignoring Health Equity in the DGA
The 2025‑2030 Dietary Guidelines for Americans (DGA) rejected 30 of the 56 recommendations from the Dietary Guidelines Advisory Committee (DGAC) after labeling the committee’s health‑equity focus as biased. Instead, the administration relied on a newly commissioned “Scientific Foundation” report that...
Glaukos to Present Multiple Scientific Abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Glaukos Corporation will present a slate of scientific abstracts at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) meeting in Washington, D.C., and will exhibit at booth #407. The company is also sponsoring an educational symposium on Epioxa™,...
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting
Bausch + Lomb announced it will present 45 scientific papers and posters at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, D.C., from April 9‑13, 2026. The sessions will feature data on its ELIOS minimally‑invasive...
African Patients and Trialists Largely Left Out of CV Research
A new study reveals that African populations are dramatically underrepresented in cardiovascular clinical trials, with less than 4 % of 2,472 randomized controlled trials (RCTs) conducted exclusively in Africa and only 0.6 % appearing in top cardiology journals. Lead author Bamba Gaye...
5 Warning Signs of a Skull Fracture That May Turn Fatal
Skull fractures can become fatal if five key warning signs are missed: loss of consciousness, unequal pupils, worsening headache, fluid leaking from the nose or ears, and seizures. These symptoms indicate brain injury, bleeding, or increased intracranial pressure and require...
STAT+: Pharmalittle: We’re Reading About an FDA Delay Forcing a Biotech to Close, a Neurocrine Deal, and More
In February, Kezar Life Sciences secured an FDA agreement for a clinical trial on autoimmune hepatitis, but the meeting was cancelled four months late, prompting the biotech to begin winding down. Meanwhile, U.S. physicians are increasingly prescribing oral GLP‑1 weight‑loss...
Hypercortisolism Common in Patients with Resistant Hypertension
The MOMENTUM study of 1,086 patients with resistant hypertension found that 27.3% had endogenous hypercortisolism. Nearly a quarter of those positive cases displayed adrenal nodules, and 21.5% also had primary hyperaldosteronism, with 5.9% harboring both disorders. Hypercortisolism was associated with...
Key Takeaways From AACE’s 2026 Type 2 Diabetes Algorithm
American Association of Clinical Endocrinology (AACE) released its 2026 consensus algorithm for managing adult type 2 diabetes, the first revision since 2023. The update introduces a diagnostic classification chart to confirm type 2 diabetes and adds metabolic dysfunction‑associated steatotic liver disease (MASLD)...
Rethinking eCOA: Why Earlier Input by Data Managers Is Needed
Electronic clinical outcome assessment (eCOA) is a mature technology, yet its adoption lags behind other digital trial tools. The traditional siloed approach forces data managers to engage only after data collection, inflating costs and extending timelines. Involving data managers early...
Engineered Antibodies Pry Apart The Most Difficult Viruses
Researchers have engineered a bifunctional antibody fragment that simultaneously blocks Marburg virus attachment and neutralizes the exposed receptor‑binding site after the virus undergoes its conformational change. By mimicking the host cell receptor, the antibody tightly binds the viral protein, shutting...
Democratizing Innovation with Agentic AI
Microsoft’s new low‑code AI platform lets healthcare staff build custom agents without programming expertise, enabling rapid solutions for clinical and back‑office challenges. By offering drag‑and‑drop interfaces and pre‑built connectors to electronic health records and billing systems, the tool democratizes agentic...
Myeloma Survival Breakthrough: Two Decades After Dalton’s Wish
I remember interviewing Bill Dalton in 2005 about new developments in myeloma and how he wished for new regimens to take OS out beyond 3-4 yrs. Two decades on we've hit jackpot...